Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 68071-2302

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-2302). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2302 3)

NuCare Pharmaceuticals, Inc. Atorvastatin Calcium 40 mg film coated tablets package label for prescription use. The label indicates #30 tablets, with instructions to take once a day. The product is manufactured by MSNL Laboratories Private Limited, Telangana, India and packaged by NuCare Pharmaceuticals, Inc. The label includes the NDC 68071-2302-3 and warning to keep out of reach of children along with storage conditions at 68-77°F.*

FDA Label Image

Figure-01 (Atorvastatin Figure 01)

A line graph showing cumulative incidence (%) over 3.5 years comparing Atorvastatin and Placebo. The solid line represents Atorvastatin, showing a lower cumulative incidence than the dashed line for Placebo. Hazard ratio (HR) and p-value are noted on the graph.*

FDA Label Image

Figure-02 (Atorvastatin Figure 02)

A line graph comparing cumulative hazard percentages over time between placebo and atorvastatin. The x-axis represents time to first primary endpoint over four years, and the y-axis shows cumulative hazard percentage. The atorvastatin group (solid line) shows a lower cumulative hazard than the placebo group (dashed line). A hazard ratio (HR) of 0.63 with confidence interval (0.48-0.83) and p-value 0.001 is noted.*

FDA Label Image

Figure-03 (Atorvastatin Figure 03)

A line graph comparing the percentage of subjects experiencing a cardiovascular event over time for Atorvastatin 10 mg and 80 mg doses. The x-axis shows time to first major cardiovascular endpoint in years (0 to 5), and the y-axis shows the percentage of subjects experiencing the event (0 to 0.2). The 10 mg dose is represented by a dashed line, and the 80 mg dose by a solid line, with the 80 mg dose showing a lower incidence over time.*

FDA Label Image

Structure (Atorvastatin Structure)

Chemical structure of atorvastatin calcium showing the molecular arrangement, including phenyl groups, hydroxyl groups, and calcium ion complex with associated water molecules (3H2O).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.